GlassScriptPhysician profile
David B Hogue
NPI 1538174933
$15,707.90
in general payments reported to CMS, 2019-2025
55 companies · $1,898 in 2025
The $1,898 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,043 · 2020: $2,031 · 2021: $2,863 · 2022: $2,306 · 2023: $2,383 · 2024: $2,184 · 2025: $1,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,365 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,365.32 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,984.32 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,657.35 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $951.88 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $906.37 | 2019-2025 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $874.83 | 2019-2022 | |
| Pfizer INC. | $767.64 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $703.20 | 2019-2025 | Spravato |
| Lilly USA, LLC | $666.71 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $643.30 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.75 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $491.90 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $474.64 | 2019-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $424.33 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $359.00 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $280.43 | 2019-2023 | Trintellix |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $277.49 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $271.07 | 2019-2024 | Verquvo, Belsomra, Dificid |
| Astellas Pharma US INC | $266.27 | 2021-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $222.28 | 2023-2024 | Rexulti, Jynarque |
| Phathom Pharmaceuticals, INC. | $156.45 | 2025 | Voquezna |
| Boston Scientific Corporation | $152.66 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Access System |
| Allergan, INC. | $148.18 | 2019-2020 | |
| Horizon Therapeutics Plc | $132.89 | 2020-2021 | |
| Dexcom, INC. | $129.89 | 2022-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $108.08 | 2021-2023 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $97.98 | 2021 | |
| Eisai INC. | $93.40 | 2020-2021 | |
| Neos Therapeutics, LP | $89.37 | 2020-2021 | |
| Corcept Therapeutics | $85.77 | 2025 | Korlym |
| Esperion Therapeutics, INC. | $70.19 | 2020-2024 | Nexletol |
| Edwards Lifesciences Corporation | $58.70 | 2019-2025 | Sapien 3 Ultra Resilia |
| Biohaven Pharmaceutical Holding Company LTD. | $52.31 | 2022 | |
| Ironwood Pharmaceuticals, INC | $51.56 | 2019-2020 | |
| Mylan Specialty L.P. | $50.92 | 2022-2023 | Yupelri |
| Exact Sciences Corporation | $40.78 | 2023-2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $36.26 | 2019-2020 | |
| Corium, LLC | $34.75 | 2023-2024 | Azstarys |
| Antares Pharma, INC. | $29.68 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Sanofi Pasteur INC. | $29.04 | 2021-2023 | |
| Globus Medical, INC. | $26.25 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $26.00 | 2021 | |
| Ascendis Pharma Endocrinology INC | $24.94 | 2025 | Yorvipath |
| Echosens North America, INC. | $24.92 | 2023 | Fibroscan |
| Xeris Pharmaceuticals, INC. | $21.41 | 2025 | Keveyis |
| Supernus Pharmaceuticals, INC. | $21.08 | 2019 | |
| Abiomed | $19.81 | 2025 | |
| Idorsia Pharmaceuticals US INC | $19.80 | 2024 | Quviviq |
| Medtronic, INC. | $18.99 | 2023 | Venaseal |
| Ucb, INC. | $18.62 | 2025 | Rystiggo |
| Stryker Corporation | $16.58 | 2025 | Clottriever Bold Catheter |
| Biofire Diagnostics, LLC | $13.21 | 2020 | |
| Currax Pharmaceuticals LLC | $12.33 | 2021 | |
| Adlon Therapeutics L.P. | $12.26 | 2020 | |
| Daiichi Sankyo INC. | $12.20 | 2019 | |
| Vistapharm, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.